2 completed. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Topical Beremagene Geperpavec: new trials by email Literature Review of Topical Beremagene Geperpavec trials Research Report on Topical Beremagene Geperpavec
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB Topical Beremagene Geperpavec, Placebo - Dystrophic Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa | Phase 3 | Completed | Krystal Biotech, Inc. | 31 | 2020-08-17 | 2023-02-17 |
| A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients Topical beremagene geperpavec, Placebo gel - Dystrophic Epidermolysis Bullosa | Phase 1 / Phase 2 | Completed | Krystal Biotech, Inc. | 12 | 2018-05-06 | 2023-01-31 |
Epidermolysis Bullosa Dystrophica (2)
United States (2)